Page 10

CSDX·June 23, 2026·restatement

CS Diagnostics Says Years of Financials Cannot Be Trusted, Plans Restatement After Removing $499 Million Asset

CS Diagnostics Corp. told investors it can no longer rely on its financial statements from 2022 through 2025 after concluding a $499.4 million intangible asset was improperly recorded.

ESSI·June 23, 2026·litigation

Eco Science Solutions Reports Modest Revenue Start While Carrying Defaulted Legal Settlement Debt

Eco Science Solutions posted its first $253 in revenue from its Herbo Pay platform but remains a going concern with a defaulted promissory note tied to a settled shareholder derivative lawsuit.

FDCT·June 23, 2026·restatement

FDCTech Expands Non-Reliance Warning to All 2024 Quarterly Reports

The company now says its first, second, and third quarter 2024 financial statements can no longer be trusted, extending a restatement that began with its full-year 2024 audit.

AMPG·June 22, 2026·restatement

AmpliTech Faces Potential Derivative Lawsuit Over 2024 Crypto Fraud Loss

AmpliTech Group disclosed that a shareholder intends to file a derivative lawsuit over a $3.2 million digital currency fraud the company suffered in 2024, an incident the company says it already investigated and remediated.

AVAV·June 22, 2026·restatement

AeroVironment Restates Quarterly Results After $89 Million Goodwill Error, Discloses Material Weakness and Board Departures

AeroVironment is restating its January 2026 quarterly financials after an $89.4 million goodwill impairment calculation error inflated its Space unit's carrying value.

POWW·June 22, 2026·settlement

Outdoor Holding Settles Digital Cash Processing Lawsuit for $4.4 Million

Outdoor Holding Company resolved its litigation with Digital Cash Processing by agreeing to pay $4.4 million, removing a legal overhang as the company focuses on its GunBroker marketplace following the sale of its ammunition business.

SEM·June 22, 2026·litigation

Select Medical Supplements Proxy Disclosures After Shareholder Lawsuits Challenge Merger Details

Select Medical added new financial details to its merger proxy statement after three shareholder lawsuits and eleven demand letters alleged the original disclosures omitted material information about the $16.50-per-share buyout.

← Newer posts

Record Alpha uses automated systems to identify and summarize public filings, court records, and regulatory actions as they become available. Every article links directly to the primary source document so readers can verify details firsthand. This content is for informational purposes only and is not investment, legal, or financial advice. Full disclaimer →

DisclaimerPrivacyTermsContact

© 2026 Record Alpha. All rights reserved.